RecruitingNCT03192774
The Prospective Segeberg TAVI Registry
A Prospective Follow-up Assessment of Transcatheter Aortic Valve Implantation in Bad Segeberg
Sponsor
Segeberger Kliniken GmbH
Enrollment
2,000 participants
Start Date
Sep 1, 2007
Study Type
OBSERVATIONAL
Conditions
Summary
A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria1
- All patients treated with TAVI
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICETranscatheter Aortic Valve Implantation
Interventional replacement of the aortic valve
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03192774
Related Trials
Smartphone Based Digital Screening for Aortic Valve Stenosis
NCT072845501 location
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NCT037280499 locations
The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration (POPular PET TAVI)
NCT057586624 locations
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT072767112 locations
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
NCT0655779869 locations